Concepedia

Rongji Mu

RM

Statistics

Publications

6

Citations

226

H-Index

6

Active since

2018

Affiliations

Shanghai Jiao Tong University(Current)

Shanghai Institute of Hematology

Ruijin Hospital

Institut Français de la Vigne et du Vin

Clinical Research Institute

Rongji Mu is an author at Shanghai Jiao Tong University specializing in oncology, immunology, and bayesian dose escalation.

Publications per year

2018–2025

6

Publications

6

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial

Mu‐Chen Zhang, Shuang Tian, Di Fu et al. · Cancer Cell · 2023 · 117 citations · Full text

Medicine, Immunology, Oncology +14

gBOIN: A Unified Model-Assisted Phase I Trial Design Accounting for Toxicity Grades, and Binary or Continuous End Points

Rongji Mu, Ying Yuan, Jin Xu et al. · Journal of the Royal Statistical Society Series C (Applied Statistics) · 2018 · 49 citations

Pharmacy, Biostatistics, Pharmacology +13

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma

Yue Wang, Qing Shi, Zi‐Yang Shi et al. · Blood Advances · 2024 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Bayesian adaptive phase I/II platform trial design for pediatric immunotherapy trials

Rongji Mu, Haitao Pan, Guoying Xu · Statistics in Medicine · 2020 · 16 citations

Medicine, Immunology, Oncology +17

Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial

Qing Shi, Yang He, Hongmei Yi et al. · Cancer Communications · 2023 · 12 citations · Full text

Medicine, Hematology, Oncology +13

1–5 of 6